ANKTIVA vs OPDIVO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. ANKTIVA and OPDIVO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ANKTIVA	OPDIVO
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	nogapendekin alfa inbakicept-pmln	NIVOLUMAB
Manufacturer	Altor Bioscience, LLC, An Indirect Wholly-Owned Su	Bristol Myers Squibb
Dosage forms	Solution	Injectable
Drug class	Interleukin-15 Receptor Agonist	Programmed Death Receptor-1 Blocking Antibody
Boxed warning	None	None
Treats	Urinary Bladder Neoplasms	Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma

anktiva opdivo

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

nogapendekin alfa inbakicept-pmln

NIVOLUMAB

Manufacturer

Altor Bioscience, LLC, An Indirect Wholly-Owned Su

Bristol Myers Squibb

Dosage forms

Solution

Injectable

Drug class

Interleukin-15 Receptor Agonist

Programmed Death Receptor-1 Blocking Antibody

Boxed warning

None

Treats

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma

Frequently asked questions

What is the difference between Anktiva and Opdivo?

Anktiva contains Nogapendekin Alfa Inbakicept-Pmln, while Opdivo contains Nivolumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.